Related Experiment Videos
[Lung cancer--diagnosis and therapy delay]
E Radzikowska1, K Roszkowski, P Głaz
1III Kliniki Gruźlicy i Chorób Płuc Instytutu Gruźlicy i Chorób Płuc w Warszawie.
Pneumonologia I Alergologia Polska
|July 24, 2002
Summary
Delays in lung cancer diagnosis and therapy are significant across Poland, with patient and physician factors contributing to prolonged waiting times. Further evaluation of these delays is crucial for improving patient outcomes.
Area of Science:
- Oncology
- Public Health
- Health Services Research
Context:
- Lung cancer diagnosis and treatment require timely intervention for optimal patient outcomes.
- Significant variations in diagnosis and therapy timelines exist within Poland.
- Understanding patient and physician-related delays is critical for healthcare system improvement.
Purpose:
- To assess the extent of diagnostic and therapeutic delays in a large cohort of lung cancer patients across Poland.
- To identify key factors contributing to delays in the lung cancer care pathway.
- To provide data for targeted interventions to reduce delays.
Summary:
- This study analyzed 20,561 lung cancer patients registered between 1995-1998.
- Median patient-attributed delay was 46 days; median physician-attributed delay (first visit to diagnosis) was 65 days.
- Median time from first doctor visit to therapy initiation was 84 days, with diagnosis-to-therapy taking 30 days. Delays related to chest physicians were also significant.
Impact:
- Findings highlight substantial, province-level variations in lung cancer diagnosis and therapy delays.
- Identifies family doctors and chest physicians as key contributors to delays, necessitating further investigation.
- Results underscore the need for systemic improvements to expedite lung cancer patient care pathways.